Lv1
50 积分 2025-09-10 加入
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
1个月前
已完结
De novo design of a fusion protein tool for GPCR research
3个月前
已完结
De novo design and structure of a peptide–centric TCR mimic binding module
6个月前
已完结
High-throughput synthesis and specificity characterization of natively paired influenza hemagglutinin antibodies with oPool + display
6个月前
已完结
皖公网安备34019202002308
